| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/01/1992 | WO1992003469A1 Genetic material encoding igfbp-4 |
| 03/01/1992 | WO1992003152A1 New insulin-like growth factor binding protein (igfbp-4) |
| 03/01/1992 | CA2090705A1 Genetic material encoding igfbp-5 |
| 03/01/1992 | CA2090704A1 Genetic material encoding igfbp-4 |
| 03/01/1992 | CA2090703A1 Insulin-like growth factor binding protein (igfbp-4) |
| 03/01/1992 | CA2090702A1 Insulin-like growth factor binding protein igfbp-5 |
| 03/01/1992 | CA2090464A1 Method for treating endotoxin shock using anti-adhesion antibodies |
| 03/01/1992 | CA2089761A1 Method and compositions for diagnosing and treating chronic fatique immunodysfunction syndrome |
| 03/01/1992 | CA2072105A1 Mutation of hrv2 2a |
| 03/01/1992 | CA2067249A1 Method for rapid selection of efficient secretion vectors |
| 03/01/1992 | CA2050451A1 Dna and polypeptide for tumor-associated antigen co-029 |
| 03/01/1992 | CA2049883A1 Monoclonal antibody specifically reactive with human perforin |
| 03/01/1992 | CA2049879A1 Controlled initial target-dependent production of templates for ligase chain reaction |
| 02/28/1992 | WO1992003538A1 METHODS FOR PRODUCING RNA VIRUSES FROM cDNA |
| 02/28/1992 | WO1992003459A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 02/28/1992 | CA2090486A1 Human zona pellucida protein zp3 |
| 02/28/1992 | CA2090469A1 Ligand for the c-kit receptor and methods of use thereof |
| 02/28/1992 | CA2024096A1 Gene clone for the human dopamine d1 receptor |
| 02/27/1992 | DE4026964A1 New infectious acid-resistant rhinovirus strain - is e.g. mutant of serotype 14; for treating rhinovirus infection |
| 02/26/1992 | WO1992003458A1 Non-a, non-b hepatitis virus antigen, diagnostic methods and vaccines |
| 02/26/1992 | EP0472498A1 Monoclonal antibodies to leptosphaeria |
| 02/26/1992 | EP0472494A2 Anti-pathogenic biocontrol agents, genes encoding antibiotics synthesis and the use of said antibiotics |
| 02/26/1992 | EP0472434A2 Antisense oligonucleotides complementary to the macromolecular synthesis operon of bacteria, and their uses in diagnosis and therapy |
| 02/26/1992 | EP0472399A2 HLA-DR antigen gene, its nucleotide sequence and its use |
| 02/26/1992 | EP0472286A1 Gene encoding candida albicans plasma membrane H+ATPase |
| 02/26/1992 | EP0472207A2 Hepatitis C assay utilizing recombinant antigens |
| 02/26/1992 | EP0472011A1 Composition containing protease produced by vibrio and method of use in debridement and wound healing |
| 02/26/1992 | EP0471832A1 Improved expression of polypeptides |
| 02/26/1992 | EP0471804A1 Novel human cyclin a compositions and their production method, a corresponding nucleotide sequence, a method and agents for detecting or diagnosing cell multiplication, and a method and agents for inhibiting cell multiplication |
| 02/26/1992 | EP0471796A1 Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter |
| 02/26/1992 | EP0471793A1 Improved forms of basic fibroblast growth factor |
| 02/26/1992 | EP0471787A1 A plasmid dna construct including the gene encoding a mammalian beta-nerve growth factor |
| 02/26/1992 | EP0471778A1 Herpes simplex virus type 2-glycoprotein g proteins and polypeptides |
| 02/26/1992 | EP0471759A1 HIGH LEVEL EXPRESSION OF FUNCTIONAL HUMAN PLASMINOGEN ACTIVATOR INHIBITOR (PAI-1) IN $i(E. COLI) |
| 02/26/1992 | EP0471752A1 Polypeptides of feline t-cell lymphotropic lentivirus |
| 02/26/1992 | EP0471687A1 Methods and nucleic acid sequences for the expression of the cellulose synthase operon |
| 02/26/1992 | EP0247145B1 Multiply-amplifiable vectors for high level expression of exogenous dna |
| 02/26/1992 | EP0218712B1 Novel procoagulant proteins |
| 02/26/1992 | EP0211037B1 METHOD OF PRODUCING HIGH MOLECULAR WEIGHT SODIUM HYALURONATE BY FERMENTATION OF $i(STREPTOCOCCUS) |
| 02/26/1992 | CN1058990A Protein structure of plant toxin gelonin |
| 02/26/1992 | CA2090335A1 Non-a, non-b hepatitis virus antigen, diagnostic methods and vaccines |
| 02/25/1992 | WO1992003567A1 Dna amplification fingerprinting |
| 02/25/1992 | WO1992003461A1 Methods of synthesizing oligonucleotides with random codons |
| 02/25/1992 | US5091518 Beta retinoic acid response elements compositions and assays |
| 02/25/1992 | US5091513 Biosynthetic antibody binding sites |
| 02/25/1992 | US5091376 Of flucose and galactose; stoichiometry |
| 02/25/1992 | US5091314 Replicating extachromosomal element from escherichia and a multicopy plasmid |
| 02/25/1992 | US5091309 Sindbis virus vectors |
| 02/25/1992 | US5091303 Binding of monoclonal antibody to pure p29 protein |
| 02/25/1992 | US5091177 Monoclonal antibodies for treatment of human non-small cell lung carcinomas |
| 02/25/1992 | CA2090015A1 Dna amplification fingerprinting |
| 02/25/1992 | CA1296276C DNA STRAND CODING FOR .alpha.-ACETOLACTATE DECARBOXYLASE AND YEAST TRANSFORMED WITH THE DNA STRAND |
| 02/25/1992 | CA1296275C Monoclonal antibody, hybridoma, their production and use thereof |
| 02/25/1992 | CA1296273C Recombinant methods for production of serine protease inhibitors and methods for isolation of same |
| 02/25/1992 | CA1296272C Superoxide dismutase cloning and expression in microorganisms |
| 02/25/1992 | CA1296271C Promoter arrangement for streptomycetes vectors |
| 02/25/1992 | CA1296270C Sex determination in ruminants using y-chromosome specific polynucleotides |
| 02/25/1992 | CA1296242C Competitive homogeneous assay |
| 02/24/1992 | WO1992003158A1 Nucleotide and amino acid sequences of protein mtp40 of m. tuberculosis and synthetic peptides derived therefrom |
| 02/24/1992 | CA2089888A1 Nucleotide and amino acid sequences of protein mtp40 of m. tuberculosis and synthetic peptides derived therefrom |
| 02/24/1992 | CA2049538A1 Chondromodulin-i protein |
| 02/21/1992 | WO1992003735A1 Liver fluke diagnostic system |
| 02/21/1992 | CA2089157A1 Liver fluke diagnostic system |
| 02/21/1992 | CA2067337A1 Methods for producing rna viruses from cdna |
| 02/21/1992 | CA2049401A1 Heparin binding neurotrophic factor gene sequence |
| 02/21/1992 | CA2049385A1 Anti-pathogenic biocontrol agents, genes encoding antibiotics synthesis and the use of said antibiotics |
| 02/21/1992 | CA2049370A1 Human mk gene and protein sequence |
| 02/20/1992 | WO1992002820A1 Monoclonal antibody to enterohemorrhagic escherichia coli 0157:h7 and 026:h11 and method for detection |
| 02/20/1992 | WO1992002692A1 Method for building an underground construction, particularly a vehicle park, while leaving in place obstacles such as trees |
| 02/20/1992 | WO1992002642A1 Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus |
| 02/20/1992 | WO1992002633A1 Methods for rapid microbial detection |
| 02/20/1992 | WO1992002626A1 Eliminating internal initiation of soluble cd4 gene |
| 02/20/1992 | WO1992002625A1 Pharmaceutical compositions containing superoxide dismutase from bacillus stearothermophilus and bacillus caldotenax |
| 02/20/1992 | WO1992002624A1 Cloning and expression of toxoplasma antigens and use of recombinant antigens |
| 02/20/1992 | WO1992002623A1 CLONING AND EXPRESSION OF A RHOPTRY ASSOCIATED PROTEIN OF $i(P.FALCIPARUM) |
| 02/20/1992 | WO1992002622A1 Novel gene complex particularly useful for modifying plants such as cucumis melo, and cucumis melo incorporating said gene complex |
| 02/20/1992 | WO1992002620A1 Chimeric neurotrophic factors |
| 02/20/1992 | WO1992002618A1 Animal models for thrombopathies and cardiopathies |
| 02/20/1992 | WO1992002615A1 Serine protease variants having peptide ligase activity |
| 02/20/1992 | WO1992002612A2 Tissue plasminogen activator variants with decreased clearance |
| 02/20/1992 | WO1992002558A1 Method of purifying cytokeratin 20, and the use of cytokeratin 20 to produce antibodies |
| 02/20/1992 | WO1992002557A1 arg A HUMAN GENE RELATED TO BUT DISTINCT FROM abl PROTO-ONCOGENE |
| 02/20/1992 | WO1992002554A1 Nuclear phosphoproteins for prognosticating lymphoid or epithelial cancers |
| 02/20/1992 | WO1992002550A1 Expression of recombinant polypeptides with improved purification |
| 02/20/1992 | WO1992002548A1 Recombinant baculovirus expressing proteins e and ns1 of flaviviridae viruses and flaviviridae-related viruses |
| 02/20/1992 | WO1992002539A1 Process for the enzymatic preparation of basic fibroblast growth factor |
| 02/20/1992 | WO1992002536A1 Systematic polypeptide evolution by reverse translation |
| 02/20/1992 | WO1992002535A1 Automated system for polynucleotide synthesis and purification |
| 02/20/1992 | WO1992002531A1 Novel polyamine conjugated oligonucleotides |
| 02/20/1992 | WO1992002529A1 Expression vectors regulated by estrogen and a mutant estrogen receptor |
| 02/20/1992 | WO1992002258A1 Nuclease resistant, pyrimidine modified oligonucleotides that detect and modulate gene expression |
| 02/20/1992 | WO1992002252A1 The gene encoding equine herpesvirus type 1 glycoprotein d, its gene product, antibodies and their uses |
| 02/20/1992 | WO1992002246A1 Growth factor compositions, preparation and use |
| 02/20/1992 | WO1992002236A1 Agent for preventing and treating hepatitis |
| 02/20/1992 | WO1992002228A1 Viral (hiv) growth inhibition |
| 02/20/1992 | WO1992002142A1 High viscosity bacteria, bacterial compositions, and methods |
| 02/20/1992 | WO1992002139A1 Insecticidal proteins |
| 02/20/1992 | WO1991019736A3 Cancer-associated scm-recognition factor, preparation and method of use |
| 02/20/1992 | DE4025725A1 Monoklonale antikoerper, die mit human- und ratteninsulin bindefaehig sind Monoclonal antibodies that are human and rat insulin with bindefaehig |
| 02/20/1992 | CA2088990A1 Chimeric neurotrophic factors |